Elevated circulating levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and high-sensitivity capsular reactive protein (hs-CRP), which can impair insulin resistance and thereby reduce glycemic control, have been shown in a previous study [11]. The gene discussed is TNF; the disease is Insulin resistance.